251 related articles for article (PubMed ID: 7543517)
21. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
Fan K; Wang H; Wei H; Zhou Q; Kou G; Hou S; Qian W; Dai J; Li B; Zhang Y; Zhu T; Guo Y
Transplantation; 2007 Sep; 84(6):746-54. PubMed ID: 17893608
[TBL] [Abstract][Full Text] [Related]
22. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
[TBL] [Abstract][Full Text] [Related]
23. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
24. Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig.
Feng S; Quickel RR; Hollister-Lock J; McLeod M; Bonner-Weir S; Mulligan RC; Weir GC
Transplantation; 1999 Jun; 67(12):1607-13. PubMed ID: 10401769
[TBL] [Abstract][Full Text] [Related]
25. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
26. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation.
Levisetti MG; Padrid PA; Szot GL; Mittal N; Meehan SM; Wardrip CL; Gray GS; Bruce DS; Thistlethwaite JR; Bluestone JA
J Immunol; 1997 Dec; 159(11):5187-91. PubMed ID: 9548454
[TBL] [Abstract][Full Text] [Related]
27. Transplantation tolerance induced by CTLA4-Ig.
Pearson TC; Alexander DZ; Winn KJ; Linsley PS; Lowry RP; Larsen CP
Transplantation; 1994 Jun; 57(12):1701-6. PubMed ID: 8016872
[TBL] [Abstract][Full Text] [Related]
28. Costimulation and its role in organ transplantation.
Bluestone JA
Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
[TBL] [Abstract][Full Text] [Related]
29. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
Newell KA; He G; Guo Z; Kim O; Szot GL; Rulifson I; Zhou P; Hart J; Thistlethwaite JR; Bluestone JA
J Immunol; 1999 Sep; 163(5):2358-62. PubMed ID: 10452966
[TBL] [Abstract][Full Text] [Related]
30. The role of donor and recipient B7-1 (CD80) in allograft rejection.
Zheng XX; Sayegh MH; Zheng XG; Li Y; Linsley PS; Peach R; Borriello F; Strom TB; Sharpe AH; Turka LA
J Immunol; 1997 Aug; 159(3):1169-73. PubMed ID: 9233610
[TBL] [Abstract][Full Text] [Related]
31. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
Kosuge H; Suzuki J; Gotoh R; Koga N; Ito H; Isobe M; Inobe M; Uede T
Transplantation; 2003 Apr; 75(8):1374-9. PubMed ID: 12717233
[TBL] [Abstract][Full Text] [Related]
32. CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice.
Yang DF; Qiu WH; Zhu HF; Lei P; Wen X; Dai H; Zhou W; Shen GX
Transpl Immunol; 2008 Jul; 19(3-4):197-201. PubMed ID: 18667318
[TBL] [Abstract][Full Text] [Related]
33. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity.
Baliga P; Chavin KD; Qin L; Woodward J; Lin J; Linsley PS; Bromberg JS
Transplantation; 1994 Nov; 58(10):1082-90. PubMed ID: 7526493
[TBL] [Abstract][Full Text] [Related]
34. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
35. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
Tao X; Constant S; Jorritsma P; Bottomly K
J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
[TBL] [Abstract][Full Text] [Related]
36. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
[TBL] [Abstract][Full Text] [Related]
37. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
[TBL] [Abstract][Full Text] [Related]
38. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival.
Gorczynski RM; Cattral MS; Chen Z; Hu J; Lei J; Min WP; Yu G; Ni J
J Immunol; 1999 Aug; 163(3):1654-60. PubMed ID: 10415071
[TBL] [Abstract][Full Text] [Related]
39. Allogenic donor splenocytes pretreated with antisense peptide against B7 prolong cardiac allograft survival.
Chen J; He Q; Zhang R; Chu Y; Wang Y; Liu Q; Xiong S
Clin Exp Immunol; 2004 Nov; 138(2):245-50. PubMed ID: 15498033
[TBL] [Abstract][Full Text] [Related]
40. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
Saito K; Sakurai J; Ohata J; Kohsaka T; Hashimoto H; Okumura K; Abe R; Azuma M
J Immunol; 1998 May; 160(9):4225-31. PubMed ID: 9574523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
